Dual inhibition of interleukin-1 receptor-associated kinases (IRAK-4 and IRAK-1), downstream mediators of TLR signaling, suppresses the expression of anti-apoptotic proteins such as Bcl-2 and Bcl-xL in chemoresistant HNSCC. Here, IRAK1 is linked to head and neck squamous cell carcinoma.